Phase 4 Chronic rhinosinusitis Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Rigshospitalet, Denmark135 enrolled9 locationsNCT07187583
Recruiting
Phase 4
Identifying Predictors Of Response To Mepolizumab In CRSwNP
Chronic Rhinosinusitis With Nasal Polyps
Centre hospitalier de l'Université de Montréal (CHUM)36 enrolled1 locationNCT05902325
Recruiting
Phase 4
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
Chronic Rhinosinusitis With Nasal PolypsOlfactory Disorder
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's27 enrolled1 locationNCT04869436
Recruiting
Phase 4
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
AsthmaChronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis Without Nasal Polyps
St. Paul's Sinus Centre90 enrolled1 locationNCT05642806
Not Yet Recruiting
Phase 4
Evaluating the additional effect of clarithromycin in the standard of care for non-eosinophilic Chronic Rhinosinusitis patients
Chronic rhinosinusitis
Professor Alkis Psaltis50 enrolled1 locationACTRN12621000688886
Active
Phase 4
Doxycycline after sinus surgery
Chronic rhinosinusitis
Dr. Andrew James Wood50 enrolled1 locationACTRN12621000674831
Recruiting
Phase 4
Mometasone irrigation in the treatment of chronic rhinosinusitis
Chronic rhinosinusitis
A/Prof Richard Harvey60 enrolled1 locationACTRN12612000866808
Not Yet Recruiting
Phase 4
The use of the oral antibiotic, roxithromycin, prior to endoscopic surgery of the paranasal sinuses, to improve the surgical field and outcomes
Chronic rhinosinusitis
Royal Victorian Eye and Ear Hospital58 enrolled1 locationACTRN12611000485932